Skip to main content
Rathi Pillai, MD, Oncology, Atlanta, GA, Grady Memorial Hospital

RathiNarayanaPillaiMD

Oncology Atlanta, GA

Assistant Professor, Hematology and Medical Oncology, Emory Univ Sch of Med

Dr. Pillai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Pillai's full profile

Already have an account?

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
  • Emory University School of Medicine
    Emory University School of MedicineResidency, Internal Medicine, 2007 - 2010
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolClass of 2007

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2013 - 2023
  • American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Concurrent Chemoradiotherapy with Weekly Versus Triweekly Cisplatin in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Comparative Analysis  
    Rathi Pillai, Fadlo R Khuri, Nabil F Saba, Conor Steuer, Suchita Pakkala, Kristin Higgins, Jonathan J Beitler, Suresh S Ramalingam, Brandon Twardy, Kelly Schrapp, Taof..., Head & Neck
  • Targeted Sequencing and Intracranial Outcomes of Patients with Lung Adenocarcinoma Brain Metastases Treated with Radiotherapy  
    Gabriel L Sica, Matthew J Ferris, Walter J Curran, Shannon Kahn, Suresh S Ramalingam, Pretesh R Patel, Rathi N Pillai, Robert H Press, Jim Zhong, Conor E Steuer, Taofe..., Cancer

Lectures

  • Current Frontline Therapy Options for Squamous Cell Carcinoma 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019

Press Mentions

  • T Cell Revival Correlates with Lung Cancer Response to PD-1 Immunotherapy
    T Cell Revival Correlates with Lung Cancer Response to PD-1 ImmunotherapyApril 24th, 2017
  • OncLive® Presents State of the Science Summit™ on Non-Small Cell Lung Cancer
    OncLive® Presents State of the Science Summit™ on Non-Small Cell Lung CancerJune 25th, 2019
  • Cancer Immunotherapy: Revived T Cells Still Need Fuel
    Cancer Immunotherapy: Revived T Cells Still Need FuelMarch 9th, 2017

Hospital Affiliations